Medovir (Aciclovir)

Aciclovir is converted inside infected cells to its active triphosphate form. This metabolite competitively inhibits the viral DNA polymerase enzyme, preventing the synthesis of viral DNA and thereby halting replication of the herpes simplex virus. The result is a reduction in viral replication at the site of application.

The dosage regimen for Medovir is determined by the prescribing healthcare professional based on the specific indication, severity of the infection, and patient factors. The prescriber will provide instructions on how often to apply the cream and for how many days.

Safety data for topical aciclovir in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using Medovir.

To order Medovir, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials. The team then replies with pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

The most common alternative topical antiviral is penciclovir cream. Both aciclovir (Medovir) and penciclovir inhibit viral DNA synthesis, but aciclovir has a longer history of use and is available over‑the‑counter in many regions. Clinical studies suggest comparable efficacy, while individual response may vary.

Medovir should be stored at temperatures below 25 °C, in its original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date printed on the packaging.

Apply a thin layer of Medovir to the affected skin area, typically five times daily, or as directed by a healthcare professional. Wash hands before and after application, avoid contact with eyes, and do not cover the treated area with airtight dressings unless advised.

While rare, serious adverse reactions can include severe allergic dermatitis, Stevens‑Johnson syndrome, or ocular irritation if the product contacts the eye. Users should discontinue the cream and seek immediate medical attention if they experience extensive rash, swelling, blistering, or visual disturbances.

Medovir should not be used by individuals with a known hypersensitivity to aciclovir or any of the excipients in the formulation. It is also contraindicated on mucous membranes, in the eyes, or on severely damaged skin without medical supervision.